Definitions, rates and associated mortality of ICU-acquired pneumonia: A multicenter cohort study.
暂无分享,去创建一个
N. Adhikari | H. Stelfox | B. Rochwerg | I. Ball | F. Lauzier | A. Kristof | Y. Arabi | D. Heels-Ansdell | R. Zarychanski | E. Charbonney | J. Muscedere | J. Centofanti | K. Khwaja | T. Karachi | L. Hand | N. Daneman | O. Loubani | J. Marshall | N. Zytaruk | J. Dionne | W. Sligl | A. Takaoka | E. Duan | Jennifer L. Y. Tsang | J. Johnstone | J. Kutsogiannis | Simon J Oczkowski | P. Dodek | D. Lamarche | D. Cook | D. Bowdish | S. Mehta | R. Fowler | Charles St Arnaud | M. Surette
[1] Paul W. Dul,et al. Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial. , 2021, JAMA.
[2] G. Guyatt,et al. Diagnosis of ventilator-associated pneumonia in critically ill adult patients—a systematic review and meta-analysis , 2020, Intensive Care Medicine.
[3] M. Klompas,et al. Ventilator-associated pneumonia in adults: a narrative review , 2020, Intensive Care Medicine.
[4] M. Surette,et al. Evaluating probiotics for the prevention of ventilator-associated pneumonia: a randomised placebo-controlled multicentre trial protocol and statistical analysis plan for PROSPECT , 2019, BMJ Open.
[5] R. Wunderink,et al. Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia , 2018, ERJ Open Research.
[6] Robert W. Taylor,et al. Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial—PROSPECT: a pilot trial , 2016, Trials.
[7] D. Sibbritt,et al. Incidence of ventilator-associated pneumonia in Australasian intensive care units: use of a consensus-developed clinical surveillance checklist in a multisite prospective audit , 2015, BMJ Open.
[8] B. Souweine,et al. Ventilator-Associated Events: Prevalence, Outcome, and Relationship With Ventilator-Associated Pneumonia* , 2015, Critical care medicine.
[9] J. Vincent,et al. Impact of diagnostic criteria on the incidence of ventilator-associated pneumonia. , 2015, Chest.
[10] S. Keenan,et al. The clinical impact and preventability of ventilator-associated conditions in critically ill patients who are mechanically ventilated. , 2013, Chest.
[11] D. Cook,et al. A randomized trial of glutamine and antioxidants in critically ill patients. , 2013, The New England journal of medicine.
[12] Stijn Vansteelandt,et al. Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis. , 2011, American journal of respiratory and critical care medicine.
[13] T. Casale,et al. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. , 2010, American journal of respiratory and critical care medicine.
[14] A. Day,et al. Mortality, attributable mortality, and clinical events as end points for clinical trials of ventilator-associated pneumonia and hospital-acquired pneumonia. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] Margaret A Dudeck,et al. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.
[16] D. Heyland,et al. The impact of ventilator-associated pneumonia on the Canadian health care system. , 2008, Journal of critical care.
[17] Sanjay Saint,et al. Clinical and economic consequences of ventilator-associated pneumonia: A systematic review , 2005, Critical care medicine.
[18] I. McDowell,et al. A global clinical measure of fitness and frailty in elderly people , 2005, Canadian Medical Association Journal.
[19] Jonathan Cohen,et al. The International Sepsis Forum Consensus Conference on Definitions of Infection in the Intensive Care Unit , 2005, Critical care medicine.
[20] A. Fein,et al. Evidence-based assessment of diagnostic tests for ventilator-associated pneumonia. Executive summary. , 2000, Chest.
[21] S. Ewig,et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies , 1999, Thorax.
[22] R. Auckenthaler,et al. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. , 1991, The American review of respiratory disease.
[23] Jacob Cohen. A Coefficient of Agreement for Nominal Scales , 1960 .
[24] M Schumacher,et al. Attributable Mortality due to Nosocomial Infections , 2007, Methods of Information in Medicine.